Chime Biologics

Full-service biologics CDMO covering cell line and process development, protein characterisation, drug substance and drug product manufacturing, quality control and regulatory support. It works with monoclonal and bispecific antibodies, fusion proteins, enzymes and vaccines. Its Wuhan plant was the world's first modular KUBio biopharmaceutical facility. Operating as an independent CDMO since March 2020.